These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36351955)

  • 41. Same-Single-Cell Analysis of Pacemaker-Specific Markers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Subtypes Classified by Electrophysiology.
    Yechikov S; Copaciu R; Gluck JM; Deng W; Chiamvimonvat N; Chan JW; Lieu DK
    Stem Cells; 2016 Nov; 34(11):2670-2680. PubMed ID: 27434649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A computational method for identifying an optimal combination of existing drugs to repair the action potentials of SQT1 ventricular myocytes.
    Jæger KH; Edwards AG; Giles WR; Tveito A
    PLoS Comput Biol; 2021 Aug; 17(8):e1009233. PubMed ID: 34383746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.
    Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ
    Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contribution of two-pore K
    Chai S; Wan X; Nassal DM; Liu H; Moravec CS; Ramirez-Navarro A; Deschênes I
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1144-H1153. PubMed ID: 28341634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Required G
    Fabbri A; Goversen B; Vos MA; van Veen TAB; de Boer TP
    Biophys J; 2019 Dec; 117(12):2303-2315. PubMed ID: 31623886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Syncytium cell growth increases Kir2.1 contribution in human iPSC-cardiomyocytes.
    Li W; Han JL; Entcheva E
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1112-H1122. PubMed ID: 32986966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultrarapid Delayed Rectifier K
    Hilderink S; Devalla HD; Bosch L; Wilders R; Verkerk AO
    Front Cell Dev Biol; 2020; 8():536. PubMed ID: 32850774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human Induced Pluripotent Stem Cell-Derived Non-Cardiomyocytes Modulate Cardiac Electrophysiological Maturation Through Connexin 43-Mediated Cell-Cell Interactions.
    Biendarra-Tiegs SM; Clemens DJ; Secreto FJ; Nelson TJ
    Stem Cells Dev; 2020 Jan; 29(2):75-89. PubMed ID: 31744402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.
    Lou X; Zhao M; Fan C; Fast VG; Valarmathi MT; Zhu W; Zhang J
    Cardiovasc Res; 2020 Mar; 116(3):671-685. PubMed ID: 31350544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.
    Parveen S; Singh SP; Panicker MM; Gupta PK
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):272-284. PubMed ID: 30798515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
    Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Electrophysiological Analysis of hiPSC-Derived Cardiomyocytes Using a Patch-Clamp Technique.
    Yamamoto Y; Hirose S; Wuriyanghai Y; Yoshinaga D; Makiyama T
    Methods Mol Biol; 2021; 2320():121-133. PubMed ID: 34302654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/- and human SCN5A-1795insD+/- iPSC-derived cardiomyocytes.
    Portero V; Casini S; Hoekstra M; Verkerk AO; Mengarelli I; Belardinelli L; Rajamani S; Wilde AAM; Bezzina CR; Veldkamp MW; Remme CA
    Cardiovasc Res; 2017 Jun; 113(7):829-838. PubMed ID: 28430892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
    El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
    Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. L-Type Calcium Channel Inhibition Contributes to the Proarrhythmic Effects of Aconitine in Human Cardiomyocytes.
    Wu J; Wang X; Chung YY; Koh CH; Liu Z; Guo H; Yuan Q; Wang C; Su S; Wei H
    PLoS One; 2017; 12(1):e0168435. PubMed ID: 28056022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrical stimulation applied during differentiation drives the hiPSC-CMs towards a mature cardiac conduction-like cells.
    Crestani T; Steichen C; Neri E; Rodrigues M; Fonseca-Alaniz MH; Ormrod B; Holt MR; Pandey P; Harding S; Ehler E; Krieger JE
    Biochem Biophys Res Commun; 2020 Dec; 533(3):376-382. PubMed ID: 32962862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Emergence of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) as a Platform to Model Arrhythmogenic Diseases.
    Pourrier M; Fedida D
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes.
    Gruber A; Edri O; Huber I; Arbel G; Gepstein A; Shiti A; Shaheen N; Chorna S; Landesberg M; Gepstein L
    JCI Insight; 2021 Jun; 6(11):. PubMed ID: 34100384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving electrical properties of iPSC-cardiomyocytes by enhancing Cx43 expression.
    Sottas V; Wahl CM; Trache MC; Bartolf-Kopp M; Cambridge S; Hecker M; Ullrich ND
    J Mol Cell Cardiol; 2018 Jul; 120():31-41. PubMed ID: 29777691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
    Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
    Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.